• Stroke · Dec 2013

    Randomized Controlled Trial

    Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery.

    • Joseph P Mathew, William D White, David B Schinderle, Mihai V Podgoreanu, Miles Berger, Carmelo A Milano, Daniel T Laskowitz, Mark Stafford-Smith, James A Blumenthal, Mark F Newman, and Neurologic Outcome Research Group (NORG) of The Duke Heart Center.
    • From the Departments of Anesthesiology (J.P.M., W.D.W., M.V.P., M.B., M.S.-S., M.F.N.), Neurology (D.T.L.), Psychiatry (J.A.B.), and Surgery (C.A.M.), Duke University Medical Center, Durham, NC; and Department of Anesthesiology, Sentara Cardiovascular Research Institute, Norfolk, VA (D.B.S.).
    • Stroke. 2013 Dec 1;44(12):3407-13.

    Background And PurposeNeurocognitive decline occurs frequently after cardiac surgery and persists in a significant number of patients. Magnesium is thought to provide neuroprotection by preservation of cellular energy metabolism, blockade of the N-methyl-D-aspartate receptor, diminution of the inflammatory response, and inhibition of platelet activation. We therefore hypothesized that intraoperative magnesium administration would decrease postoperative cognitive impairment.MethodsAfter approval by the Duke University Health System Institutional Review Board, 389 patients undergoing cardiac surgery were enrolled in this prospective, randomized, double-blind, placebo-controlled clinical trial. Subjects were randomized to receive magnesium as a 50 mg/kg bolus followed by another 50 mg/kg infusion for 3 hours or placebo bolus and infusion. Cognitive function was assessed preoperatively and again at 6 weeks postoperatively using a standardized test battery. Mean CD11b fluorescence and percentage of platelets expressing CD62P, which are markers of leukocyte and platelet activation, respectively, were assessed by flow cytometry as a secondary outcome. The effect of magnesium on postoperative cognition was tested using multivariable regression modeling, adjusting for age, years of education, baseline cognition, sex, race, and weight.ResultsAmong the 389 allocated subjects (magnesium: n=198; placebo: n=191), the incidence of cognitive deficit in the magnesium group was 44.4% compared with 44.9% in the placebo group (P=0.93). The cognitive change score and platelet and leukocyte activation were also not different between the groups. Multivariable analysis revealed a marginal interaction between treatment group and weight such that heavier subjects receiving magnesium were less likely to have cognitive deficit (P=0.06).ConclusionsMagnesium administered intravenously during cardiac surgery does not reduce postoperative cognitive dysfunction.Clinical Trial Registration Urlhttp://www.clinicaltrials.gov. Unique identifier: NCT00041392.

      Pubmed     Free full text  

      Add institutional full text...

    Notes

     
    Do you have a pearl, summary or comment to save or share?
    250 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…